Results 11 to 20 of about 344,170 (326)

Orbital Cellulitis Following Uncomplicated Glaucoma Drainage Device Surgery: Case Report and Review of Literature

open access: yesJournal of Ophthalmic & Vision Research, 2020
Purpose: Orbital cellulitis (OC) is a rare postoperative complication of glaucoma drainage device (GDD) implantation. To date, there have only been 10 reported cases of OC following GDD implantation.
Cindy X. Zheng   +6 more
doaj   +1 more source

Ciliochoroidal effusion and its association with the outcomes of micropulse transscleral laser therapy in glaucoma patients: a pilot study

open access: yesScientific Reports, 2022
We investigate the development of ciliochoroidal effusion following micropulse transscleral laser therapy (MPTLT) and evaluate the relationship between the early postoperative ciliochoroidal effusion (ECE) and short-term treatment outcomes.
Sunee Chansangpetch   +7 more
doaj   +1 more source

Comparison of Phacotrabeculectomy and Phacotrabeculectomy with Subconjunctival 5-Fluorouracil

open access: yesJournal of Nepal Medical Association, 2014
Introduction: Glaucoma is the second leading cause of blindness worldwide. Phacotrabeculectomy is a technique in which glaucoma and cataract surgery performed.
Nanda Kumari Gurung   +3 more
doaj   +3 more sources

Trabeculectomy with Suprachoroidal Derivation in Eyes with Uncontrolled Glaucoma: A Case Series with a 24-Month Follow-up

open access: yesOphthalmology and Therapy, 2019
Introduction The aim of this study was to evaluate the efficacy of trabeculectomy with suprachoroidal derivation in eyes with uncontrolled glaucoma after a 24-month follow-up period. Methods This was a prospective uncontrolled non-randomized case series.
Rodolfo A. Perez-Grossmann   +2 more
doaj   +1 more source

Case Report: Reversal and subsequent return of optic disc cupping in a myocilin (MYOC) gene-associated severe Juvenile Open-Angle Glaucoma (JOAG) patient [version 1; peer review: 2 approved]

open access: yesF1000Research, 2022
To our knowledge, this case report describes the first instance of reversal of glaucomatous optic nerve cupping in a young adult with a rare form of juvenile open-angle glaucoma (JOAG) associated with a novel variant of the myocilin gene (MYOC).
Sanchay Gupta   +5 more
doaj   +1 more source

Progression from ocular hypertension to visual field loss in the English hospital eye service [PDF]

open access: yes, 2020
Background There are more than one million National Health Service visits in England and Wales each year for patients with glaucoma or ocular hypertension (OHT).
Azuara-Blanco, A.   +5 more
core   +2 more sources

Glaucoma

open access: yesThe Lancet, 2017
Glaucoma is a heterogeneous group of diseases characterised by cupping of the optic nerve head and visual-field damage. It is the most frequent cause of irreversible blindness worldwide. Progression usually stops if the intraocular pressure is lowered by 30-50% from baseline.
Jonas, Jost B   +5 more
openaire   +4 more sources

Intraocular lens power calculations in eyes with pseudoexfoliation syndrome

open access: yesScientific Reports, 2021
To compare refractive outcomes after cataract surgery in pseudoexfoliation syndrome (PEX) and control eyes and to investigate the accuracy of 3 intraocular lens (IOL) calculation formulas in these eyes.
Aleksandra Wlaź   +3 more
doaj   +1 more source

Pharmacogenetics of ophthalmic topical β-blockers [PDF]

open access: yes, 2008
Glaucoma is the second leading cause of blindness worldwide. The primary glaucoma risk factor is elevated intraocular pressure. Topical β-blockers are affordable and widely used to lower intraocular pressure.
McCarty, Catherine A.   +4 more
core   +1 more source

Adapted motivational interviewing to improve the uptake of treatment for glaucoma in Nigeria: study protocol for a randomized controlled trial. [PDF]

open access: yes, 2014
BACKGROUND: Glaucoma is a chronic eye disease associated with irreversible visual loss. In Africa, glaucoma patients often present late, with very advanced disease.
A Ashaye   +41 more
core   +3 more sources

Home - About - Disclaimer - Privacy